TALKING EDGE: How will a vaccine change Duopharma’s fortunes?

The Edge TV 2020-08-07

Views 2.6K

Duopharma Biotech has been in the news for its potential role in the upcoming Covid-19 vaccine. Group MD Leonard Ariff Abdul Shatar assures us there is more to the company than just that.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
TALKING EDGE: Duopharma’s long-term vaccine plan
play
07:31

TALKING EDGE: Duopharma’s long-term vaccine plan
TALKING EDGE: Digi’s changing face
play
06:21

TALKING EDGE: Digi’s changing face
TALKING EDGE: How will LBS Bina fare in 2019?
play
07:07

TALKING EDGE: How will LBS Bina fare in 2019?
TALKING EDGE: The kid who changed oil
play
08:07

TALKING EDGE: The kid who changed oil
TALKING EDGE: Here’s how Fonterra Msia’s RM20m plant upgrade will pay off
play
06:41

TALKING EDGE: Here’s how Fonterra Msia’s RM20m plant upgrade will pay off
TALKING EDGE: What will inflation mean for your portfolio?
play
11:19

TALKING EDGE: What will inflation mean for your portfolio?
TALKING EDGE: Will Rhone Ma’s IPO excite investors?
play
06:12

TALKING EDGE: Will Rhone Ma’s IPO excite investors?
TALKING EDGE: Revenue Group’s E-Payment edge
play
06:09

TALKING EDGE: Revenue Group’s E-Payment edge
TALKING EDGE: Survival of the cinema
play
06:58

TALKING EDGE: Survival of the cinema
TALKING EDGE: SDS outlines winning recipe
play
05:21

TALKING EDGE: SDS outlines winning recipe
TALKING EDGE: Catching up with Nova Pharma
play
04:42

TALKING EDGE: Catching up with Nova Pharma
TALKING EDGE: Harriston’s aims for overseas recognition
play
05:23

TALKING EDGE: Harriston’s aims for overseas recognition